WO2004025265A3 - Test strip and method for determining ldl cholesterol concentration from whole blood - Google Patents

Test strip and method for determining ldl cholesterol concentration from whole blood Download PDF

Info

Publication number
WO2004025265A3
WO2004025265A3 PCT/US2003/029102 US0329102W WO2004025265A3 WO 2004025265 A3 WO2004025265 A3 WO 2004025265A3 US 0329102 W US0329102 W US 0329102W WO 2004025265 A3 WO2004025265 A3 WO 2004025265A3
Authority
WO
WIPO (PCT)
Prior art keywords
concentration
test strip
ldl cholesterol
whole blood
panel
Prior art date
Application number
PCT/US2003/029102
Other languages
French (fr)
Other versions
WO2004025265A2 (en
Inventor
Bruce Shull
Hyeon-Sook Lee Zeng
Sunil Anaokar
Gena Lynn Antonopoulos
Original Assignee
Polymer Technology Systems Inc
Bruce Shull
Hyeon-Sook Lee Zeng
Sunil Anaokar
Gena Lynn Antonopoulos
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polymer Technology Systems Inc, Bruce Shull, Hyeon-Sook Lee Zeng, Sunil Anaokar, Gena Lynn Antonopoulos filed Critical Polymer Technology Systems Inc
Priority to EP03754634A priority Critical patent/EP1540353A4/en
Priority to MXPA05002955A priority patent/MXPA05002955A/en
Priority to AU2003272453A priority patent/AU2003272453A1/en
Priority to CA002499058A priority patent/CA2499058A1/en
Publication of WO2004025265A2 publication Critical patent/WO2004025265A2/en
Publication of WO2004025265A3 publication Critical patent/WO2004025265A3/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/525Multi-layer analytical elements
    • G01N33/526Multi-layer analytical elements the element being adapted for a specific analyte
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/044Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity

Abstract

A dry phase test strip (20) and method are provided for determining the concentration of LDL in whole blood or plasma. The inventive test strip (20) includes one stack (92) or panel that measures concentration of total cholesterol and another stack (94) or panel that measures concentration of the sum total of HDL, VLDL and chylomicrons ('non-LDLs'). The difference between the values just noted is equal to the concentration of LDL cholesterol. Dry phase test strips (20) of the present invention function at room temperature and all test results are produced from pseudo-endpoint reflectance measurements such that the test method need not be timed. Also disclosed is the capability for an improved lipid panel that provides concentration in a blood sample of HDL, total cholesterol and LDL cholesterol without relying upon the Friedewald equation.
PCT/US2003/029102 2002-09-16 2003-09-16 Test strip and method for determining ldl cholesterol concentration from whole blood WO2004025265A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP03754634A EP1540353A4 (en) 2002-09-16 2003-09-16 Test strip and method for determining ldl cholesterol concentration from whole blood
MXPA05002955A MXPA05002955A (en) 2002-09-16 2003-09-16 Test strip and method for determining ldl cholesterol concentration from whole blood.
AU2003272453A AU2003272453A1 (en) 2002-09-16 2003-09-16 Test strip and method for determining ldl cholesterol concentration from whole blood
CA002499058A CA2499058A1 (en) 2002-09-16 2003-09-16 Test strip and method for determining ldl cholesterol concentration from whole blood

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41120902P 2002-09-16 2002-09-16
US60/411,209 2002-09-16

Publications (2)

Publication Number Publication Date
WO2004025265A2 WO2004025265A2 (en) 2004-03-25
WO2004025265A3 true WO2004025265A3 (en) 2004-07-01

Family

ID=31994248

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/029102 WO2004025265A2 (en) 2002-09-16 2003-09-16 Test strip and method for determining ldl cholesterol concentration from whole blood

Country Status (6)

Country Link
EP (1) EP1540353A4 (en)
AU (1) AU2003272453A1 (en)
CA (1) CA2499058A1 (en)
MX (1) MXPA05002955A (en)
WO (1) WO2004025265A2 (en)
ZA (1) ZA200502214B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7795038B2 (en) 2002-04-09 2010-09-14 Cholestech Corporation High-density lipoprotein assay device and method
US7824879B2 (en) 2007-01-09 2010-11-02 Cholestech Corporation Device and method for measuring LDL-associated cholesterol

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10204606C1 (en) 2002-01-18 2003-10-16 Cholestech Corp Device and method for high density lipoproteins
US7772007B2 (en) 2004-04-02 2010-08-10 Cholestech Corporation Assay device for direct measurement of LDL cholesterol
JPWO2009031506A1 (en) * 2007-09-05 2010-12-16 アークレイ株式会社 Low density lipoprotein (LDL) cholesterol measurement method and test piece for LDL cholesterol measurement

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5132086A (en) * 1990-02-06 1992-07-21 Chemtrak Corporation Non-instrumented cholesterol assay
US5135716A (en) * 1989-07-12 1992-08-04 Kingston Diagnostics, L.P. Direct measurement of HDL cholesterol via dry chemistry strips
US5460974A (en) * 1992-10-13 1995-10-24 Miles Inc. Method of assaying whole blood for HDL cholesterol

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3193634B2 (en) * 1996-05-29 2001-07-30 第一化学薬品株式会社 LDL cholesterol determination method
JP3441993B2 (en) * 1999-01-27 2003-09-02 松下電器産業株式会社 Cholesterol sensor
US6524864B2 (en) * 2000-12-28 2003-02-25 Aurora L. Fernandez Decastro Test strip for simultaneous detection of a plurality of analytes

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5135716A (en) * 1989-07-12 1992-08-04 Kingston Diagnostics, L.P. Direct measurement of HDL cholesterol via dry chemistry strips
US5132086A (en) * 1990-02-06 1992-07-21 Chemtrak Corporation Non-instrumented cholesterol assay
US5460974A (en) * 1992-10-13 1995-10-24 Miles Inc. Method of assaying whole blood for HDL cholesterol

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1540353A4 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7795038B2 (en) 2002-04-09 2010-09-14 Cholestech Corporation High-density lipoprotein assay device and method
US7824879B2 (en) 2007-01-09 2010-11-02 Cholestech Corporation Device and method for measuring LDL-associated cholesterol

Also Published As

Publication number Publication date
WO2004025265A2 (en) 2004-03-25
ZA200502214B (en) 2006-05-31
MXPA05002955A (en) 2005-10-18
CA2499058A1 (en) 2004-03-25
EP1540353A2 (en) 2005-06-15
EP1540353A4 (en) 2007-01-24
AU2003272453A1 (en) 2004-04-30

Similar Documents

Publication Publication Date Title
WO2005028662A3 (en) Test strip and method for determining ldl cholesterol concentration from whole blood
AU2002364741A1 (en) Test strip and method for determining hdl cholesterol concentration from whole blood of plasma
Liu et al. Reagent-free, simultaneous determination of serum cholesterol in HDL and LDL by infrared spectroscopy
Brügger et al. Quantitative analysis of biological membrane lipids at the low picomole level by nano-electrospray ionization tandem mass spectrometry
Schonfeld et al. Alterations in levels and interrelations of plasma apolipoproteins induced by diet
Anandaraja et al. Low-density lipoprotein cholesterol estimation by a new formula in Indian population
Schaefer et al. Effects of atorvastatin versus other statins on fasting and postprandial C-reactive protein and lipoprotein-associated phospholipase A2 in patients with coronary heart disease versus control subjects
Nygren et al. Liquid chromatography-mass spectrometry (LC-MS)-based lipidomics for studies of body fluids and tissues
EP1571452A4 (en) Method of quantifying small-sized low density lipoprotein
Li et al. Analysis of high density lipoproteins by a modified gradient gel electrophoresis method.
Grundy et al. Comparisons of apolipoprotein B levels estimated by immunoassay, nuclear magnetic resonance, vertical auto profile, and non-high-density lipoprotein cholesterol in subjects with hypertriglyceridemia (SAFARI Trial)
Nakano et al. Detection of apolipoproteins B-48 and B-100 carrying particles in lipoprotein fractions extracted from human aortic atherosclerotic plaques in sudden cardiac death cases
Jia et al. Relationship between total cholesterol/high-density lipoprotein cholesterol ratio, triglyceride/high-density lipoprotein cholesterol ratio, and high-density lipoprotein subclasses
Sakaue et al. Reactions of direct LDL-cholesterol assays with pure LDL fraction and IDL: comparison of three homogeneous methods
Nauck et al. Homogeneous assay for direct determination of high-density lipoprotein cholesterol evaluated
WO2004025265A3 (en) Test strip and method for determining ldl cholesterol concentration from whole blood
Heimerl et al. Lipid profiling of lipoprotein X: Implications for dyslipidemia in cholestasis
Dias et al. Sulfate-based lipids: Analysis of healthy human fluids and cell extracts
IL143057A0 (en) Methods and compositions to lower plasma cholesterol levels
WO1999007325A8 (en) Liver function test
WO2006061646A8 (en) Assay for generation of a lipid profile using fluorescence measurement
Sartore et al. High-density lipoprotein oxidation in type 2 diabetic patients and young patients with premature myocardial infarction
Warnick et al. Analytical procedures for measurement of the lipids and lipoproteins in cardiovascular risk assessment
Lee et al. ESI-MS quantitation of increased sphingomyelin in Niemann-Pick disease type B HDL
CN105555963A (en) Method and reagent for quantifying cholesterol in high density lipoprotein 3

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2499058

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2003754634

Country of ref document: EP

Ref document number: 2005/02214

Country of ref document: ZA

Ref document number: PA/a/2005/002955

Country of ref document: MX

Ref document number: 200502214

Country of ref document: ZA

WWE Wipo information: entry into national phase

Ref document number: 2003272453

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2003754634

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP